• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在慢性肝衰竭基础上发生的急性肝衰竭患者外周血 CD4(+)CD25(+)调节性 T 细胞(Tregs)表型及临床意义。

Phenotypes and clinical significance of circulating CD4(+)CD25(+) regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF).

机构信息

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China.

出版信息

J Transl Med. 2012 Sep 15;10:193. doi: 10.1186/1479-5876-10-193.

DOI:10.1186/1479-5876-10-193
PMID:22978653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3527358/
Abstract

BACKGROUND

CD4(+)CD25(+) regulatory T cells (Tregs) play an important role in maintaining immunological tolerance to self and foreign antigens. T cell receptors (TCR) reflect the composition and function of T cells. It is not universally agreed that there is a relationship between CD4(+)CD25(+) Treg frequency and the severity of acute-on-chronic liver failure (ACLF). The repertoire of TCR beta chain variable (TCRBV) regions of peripheral Tregs in ACLF patients is not well understood.

METHODS

Human PBMCs were separated and sorted into CD4(+)CD25(+) Treg subsets using density gradient centrifugation and magnetic activated cell sorting (MACS). The CD4(+)CD25(high) Treg frequency in peripheral blood of ACLF and chronic hepatitis B (CHB) patients was measured by flow cytometry. The molecular profiles of TCRBV CDR3 were determined using gene melting spectral pattern (GMSP) analysis. TCRBV gene families were cloned and sequenced when the GMSP profiles showed a single-peak.

RESULTS

CD4(+)CD25(high) Treg prevalence in peripheral blood of ACLF patients is increased significantly compared to healthy donors (HDs) (P < 0.01) and CHB patients (P < 0.01). The prevalence of CD4(+)CD25(high) Tregs in ACLF or CHB patients is positively correlated with HBV DNA load. The TCRBV11, BV13.1, BV18, BV20 are the most prevalent TCRBV in CD4(+)CD25(+) Tregs in ACLF and CHB patients. In addition, the CDR3 motifs were relatively conserved in these four TCRBV gene families.

CONCLUSIONS

The CD4(+)CD25(high) Tregs prevalence in peripheral blood is indicative of disease severity in ACLF or CHB patients. The relatively conserved TCRBV20 CDR3 motif "TGTGHSPLH" and TCRBV11 CDR3 motif "VYNEQ" may be used in helping diagnosis and treat patients with ACLF.

摘要

背景

CD4(+)CD25(+)调节性 T 细胞(Tregs)在维持对自身和外来抗原的免疫耐受方面发挥着重要作用。T 细胞受体(TCR)反映了 T 细胞的组成和功能。CD4(+)CD25(+)Treg 频率与急性加重慢性肝衰竭(ACLF)的严重程度之间是否存在关系尚未得到普遍认可。ACLF 患者外周血 Tregs 的 TCRβ链可变(TCRBV)区库的情况尚不清楚。

方法

使用密度梯度离心和磁激活细胞分选(MACS)分离和分选人 PBMC 成 CD4(+)CD25(+)Treg 亚群。通过流式细胞术测量 ACLF 和慢性乙型肝炎(CHB)患者外周血中 CD4(+)CD25(high)Treg 的频率。使用基因熔融光谱图(GMSP)分析确定 TCRBV CDR3 的分子谱。当 GMSP 谱显示单峰时,克隆和测序 TCRBV 基因家族。

结果

与健康供体(HDs)(P<0.01)和 CHB 患者(P<0.01)相比,ACLF 患者外周血中 CD4(+)CD25(high)Treg 的发生率明显升高。ACLF 或 CHB 患者中 CD4(+)CD25(high)Tregs 的发生率与 HBV DNA 载量呈正相关。TCRBV11、BV13.1、BV18 和 BV20 是 ACLF 和 CHB 患者中 CD4(+)CD25(+)Tregs 中最常见的 TCRBV。此外,这四个 TCRBV 基因家族的 CDR3 基序相对保守。

结论

外周血中 CD4(+)CD25(high)Tregs 的发生率提示 ACLF 或 CHB 患者疾病的严重程度。相对保守的 TCRBV20 CDR3 基序“TGTGHSPLH”和 TCRBV11 CDR3 基序“VYNEQ”可用于帮助诊断和治疗 ACLF 患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e445/3527358/131a3b335e42/1479-5876-10-193-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e445/3527358/8e15f778a063/1479-5876-10-193-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e445/3527358/e847b1c8f063/1479-5876-10-193-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e445/3527358/131a3b335e42/1479-5876-10-193-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e445/3527358/8e15f778a063/1479-5876-10-193-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e445/3527358/e847b1c8f063/1479-5876-10-193-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e445/3527358/131a3b335e42/1479-5876-10-193-3.jpg

相似文献

1
Phenotypes and clinical significance of circulating CD4(+)CD25(+) regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF).在慢性肝衰竭基础上发生的急性肝衰竭患者外周血 CD4(+)CD25(+)调节性 T 细胞(Tregs)表型及临床意义。
J Transl Med. 2012 Sep 15;10:193. doi: 10.1186/1479-5876-10-193.
2
The frequency and skewed T-cell receptor beta-chain variable patterns of peripheral CD4(+)CD25(+) regulatory T-cells are associated with hepatitis B e antigen seroconversion of chronic hepatitis B patients during antiviral treatment.外周血CD4(+)CD25(+)调节性T细胞的频率及T细胞受体β链可变区模式的偏态分布与慢性乙型肝炎患者抗病毒治疗期间的乙肝e抗原血清学转换相关。
Cell Mol Immunol. 2016 Sep;13(5):678-87. doi: 10.1038/cmi.2015.100. Epub 2016 Feb 22.
3
Molecular features of the complementarity determining region 3 motif of the T cell population and subsets in the blood of patients with chronic severe hepatitis B.慢性重型乙型肝炎患者血液中 T 细胞群体和亚群的互补决定区 3 基序的分子特征。
J Transl Med. 2011 Dec 8;9:210. doi: 10.1186/1479-5876-9-210.
4
Imbalance between circulating CD4+ regulatory T and conventional T lymphocytes in patients with HBV-related acute-on-chronic liver failure.HBV 相关慢加急性肝衰竭患者外周血 CD4+调节性 T 细胞与常规 T 细胞失衡。
Liver Int. 2013 Nov;33(10):1517-26. doi: 10.1111/liv.12248. Epub 2013 Jul 21.
5
[Inhibition of CD4+ CD25+ regulatory T cells in chronic hepatitis B patients].[慢性乙型肝炎患者中CD4 + CD25 +调节性T细胞的抑制作用]
Zhonghua Yi Xue Za Zhi. 2008 Feb 26;88(8):511-5.
6
Increased CD4+CD25+ regulatory T cells correlate with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patients.CD4+CD25+调节性T细胞增加与乙型肝炎病毒相关慢加急性肝衰竭患者短期预后不良相关。
J Microbiol Immunol Infect. 2015 Apr;48(2):137-46. doi: 10.1016/j.jmii.2013.11.001. Epub 2013 Dec 31.
7
The ratio of Th-17 to Treg cells is associated with survival of patients with acute-on-chronic hepatitis B liver failure.Th17 细胞与调节性 T 细胞的比值与慢加急性乙型肝炎肝衰竭患者的生存相关。
Viral Immunol. 2011 Aug;24(4):303-10. doi: 10.1089/vim.2010.0135. Epub 2011 Jul 1.
8
Aberrant peripheral blood CD4 CD25 FOXP3 regulatory T cells/T helper-17 number is associated with the outcome of patients with lymphoma.异常外周血 CD4 CD25 FOXP3 调节性 T 细胞/T 辅助-17 细胞数量与淋巴瘤患者的预后相关。
Cancer Immunol Immunother. 2020 Sep;69(9):1917-1928. doi: 10.1007/s00262-020-02591-y. Epub 2020 May 8.
9
Imbalance of interleukin-17-producing CD4 T cells/regulatory T cells axis occurs in remission stage of patients with hepatitis B virus-related acute-on-chronic liver failure.乙型肝炎病毒相关慢加急性肝衰竭患者缓解期存在白细胞介素-17 产生的 CD4 T 细胞/调节性 T 细胞轴失衡。
J Gastroenterol Hepatol. 2013 Mar;28(3):513-21. doi: 10.1111/jgh.12082.
10
Molecular profile of the T cell receptor beta variable in peripheral blood lymphocytes from chronic asymptomatic HBV carriers.慢性无症状乙肝病毒携带者外周血淋巴细胞中T细胞受体β可变区的分子特征
Pathog Dis. 2015 Mar;73(2):1-9. doi: 10.1093/femspd/ftu018. Epub 2014 Dec 4.

引用本文的文献

1
Immunological Mechanisms and Effects of Bacterial Infections in Acute-on-Chronic Liver Failure.慢性肝衰竭急性加重期细菌感染的免疫机制及影响
Cells. 2025 May 15;14(10):718. doi: 10.3390/cells14100718.
2
The Mechanisms of Systemic Inflammatory and Immunosuppressive Acute-on-Chronic Liver Failure and Application Prospect of Single-Cell Sequencing.系统性炎症和免疫抑制性慢加急性肝衰竭的机制及单细胞测序的应用前景。
J Immunol Res. 2022 Nov 2;2022:5091275. doi: 10.1155/2022/5091275. eCollection 2022.
3
The Immune Pathogenesis of Acute-On-Chronic Liver Failure and the Danger Hypothesis.

本文引用的文献

1
Molecular features of the complementarity determining region 3 motif of the T cell population and subsets in the blood of patients with chronic severe hepatitis B.慢性重型乙型肝炎患者血液中 T 细胞群体和亚群的互补决定区 3 基序的分子特征。
J Transl Med. 2011 Dec 8;9:210. doi: 10.1186/1479-5876-9-210.
2
A single institution experience with living donor liver transplantation for acute-on-chronic hepatitis B liver failure.单中心活体肝移植治疗慢性乙型肝炎急性肝衰竭的经验
Hepatogastroenterology. 2011 Jul-Aug;58(109):1267-73. doi: 10.5754/hge10148.
3
Acute-on-chronic liver failure before liver transplantation: impact on posttransplant outcomes.
急慢性肝衰竭的免疫发病机制与危险假说。
Front Immunol. 2022 Jul 14;13:935160. doi: 10.3389/fimmu.2022.935160. eCollection 2022.
4
CD200R Combined Neutrophil-Lymphocyte Ratio Predict 90-Day Mortality in HBV-Related Acute-On-Chronic Liver Failure.CD200R联合中性粒细胞与淋巴细胞比值预测乙型肝炎病毒相关慢加急性肝衰竭患者90天死亡率
Front Med (Lausanne). 2021 Dec 6;8:762296. doi: 10.3389/fmed.2021.762296. eCollection 2021.
5
Dynamic changes of T cell receptor repertoires in patients with hepatitis B virus-related acute-on-chronic liver failure.乙型肝炎病毒相关慢加急性肝衰竭患者 T 细胞受体库的动态变化。
Hepatol Int. 2020 Jan;14(1):47-56. doi: 10.1007/s12072-019-10008-x. Epub 2019 Dec 23.
6
Regulatory T-cells promote hepatitis B virus infection and hepatocellular carcinoma progression.调节性T细胞促进乙型肝炎病毒感染和肝细胞癌进展。
Chronic Dis Transl Med. 2016 Nov 9;2(2):67-80. doi: 10.1016/j.cdtm.2016.09.001. eCollection 2016 Jun.
7
Predictive value of serum ALT and T-cell receptor beta variable chain for HBeAg seroconversion in chronic hepatitis B patients during tenofovir treatment.慢性乙型肝炎患者在替诺福韦治疗期间血清谷丙转氨酶和T细胞受体β可变链对HBeAg血清学转换的预测价值
Medicine (Baltimore). 2017 Mar;96(10):e6242. doi: 10.1097/MD.0000000000006242.
8
Deregulation of Regulatory T Cells in Acute-on-Chronic Liver Failure: A Rat Model.急性-on-慢性肝衰竭中调节性T细胞的失调:大鼠模型
Mediators Inflamm. 2017;2017:1390458. doi: 10.1155/2017/1390458. Epub 2017 Jan 15.
9
The frequency and skewed T-cell receptor beta-chain variable patterns of peripheral CD4(+)CD25(+) regulatory T-cells are associated with hepatitis B e antigen seroconversion of chronic hepatitis B patients during antiviral treatment.外周血CD4(+)CD25(+)调节性T细胞的频率及T细胞受体β链可变区模式的偏态分布与慢性乙型肝炎患者抗病毒治疗期间的乙肝e抗原血清学转换相关。
Cell Mol Immunol. 2016 Sep;13(5):678-87. doi: 10.1038/cmi.2015.100. Epub 2016 Feb 22.
10
Immune mediated liver failure.免疫介导的肝衰竭
EXCLI J. 2014 Oct 1;13:1131-44. eCollection 2014.
肝移植前慢加急性肝衰竭:对移植后结局的影响。
Transplantation. 2011 Oct 27;92(8):952-7. doi: 10.1097/TP.0b013e31822e6eda.
4
Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus.资源有限环境下慢性乙型肝炎病毒感染的治疗:专家共识。
Liver Int. 2011 Jul;31(6):755-61. doi: 10.1111/j.1478-3231.2010.02373.x. Epub 2011 Feb 15.
5
Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B.替比夫定治疗慢性乙型肝炎对细胞免疫应答的影响。
Antiviral Res. 2011 Jul;91(1):23-31. doi: 10.1016/j.antiviral.2011.04.008. Epub 2011 Apr 23.
6
T-cell receptor specificity of CD8(+) Tregs in allotransplantation.移植中 CD8(+)Treg 细胞的 T 细胞受体特异性。
Immunotherapy. 2011 Apr;3(4 Suppl):35-7. doi: 10.2217/imt.11.37.
7
Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies.用于临床前过继免疫治疗研究的小鼠 CD8+和 CD4+ T 细胞的基因工程。
J Immunother. 2011 May;34(4):343-52. doi: 10.1097/CJI.0b013e3182187600.
8
Bias in the αβ T-cell repertoire: implications for disease pathogenesis and vaccination.αβ T 细胞库中的偏倚:对疾病发病机制和疫苗接种的影响。
Immunol Cell Biol. 2011 Mar;89(3):375-87. doi: 10.1038/icb.2010.139. Epub 2011 Feb 8.
9
Development of a genetically-modified novel T-cell receptor for adoptive cell transfer against renal cell carcinoma.针对肾细胞癌的过继细胞转移的新型基因修饰 T 细胞受体的开发。
J Immunol Methods. 2011 Mar 7;366(1-2):43-51. doi: 10.1016/j.jim.2011.01.002. Epub 2011 Jan 19.
10
Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines.工程病毒特异性 T 细胞,以靶向 HBV 感染的肝细胞和肝癌细胞系。
J Hepatol. 2011 Jul;55(1):103-10. doi: 10.1016/j.jhep.2010.10.025. Epub 2010 Nov 23.